We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
-1.34%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.17B
AUM Growth
+$393M
Cap. Flow
+$459M
Cap. Flow %
39.32%
Top 10 Hldgs %
24.34%
Holding
4,355
New
842
Increased
1,505
Reduced
871
Closed
1,089

Sector Composition

Rank Sector Weight
1 Financials 6.75%
2 Industrials 5.87%
3 Consumer Discretionary 5.39%
4 Technology 4.75%
5 Healthcare 3.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IFF icon
1651
International Flavors & Fragrances
IFF
$21.6B
$52K ﹤0.01%
377
-53
-12% -$7.68K
MLR icon
1652
Miller Industries
MLR
$608M
$52K ﹤0.01%
2,048
-91
-4% -$2.3K
PRIM icon
1653
Primoris Services
PRIM
$4.34B
$52K ﹤0.01%
2,095
-328
-14% -$8.41K
PSO icon
1654
Pearson
PSO
$9.87B
$52K ﹤0.01%
+4,848
New +$48.3K
RIO icon
1655
Rio Tinto
RIO
$166B
$52K ﹤0.01%
1,000
+993
+14,186% +$54.1K
SYK icon
1656
Stryker
SYK
$132B
$52K ﹤0.01%
325
-2,169
-87% -$350K
LORL
1657
DELISTED
Loral Space and Communications, Inc.
LORL
$52K ﹤0.01%
1,254
+1,200
+2,222% +$54.7K
CTB
1658
DELISTED
Cooper Tire & Rubber Co.
CTB
$52K ﹤0.01%
1,774
+115
+7% +$4.02K
PETX
1659
DELISTED
Aratana Therapeutics, Inc.
PETX
$52K ﹤0.01%
+11,781
New +$52.6K
TAHO
1660
DELISTED
Tahoe Resources Inc
TAHO
$52K ﹤0.01%
11,228
-15,899
-59% -$72.5K
AGIO icon
1661
Agios Pharmaceuticals
AGIO
$1.94B
$51K ﹤0.01%
626
+558
+821% +$43.1K
BBY icon
1662
Best Buy
BBY
$17.4B
$51K ﹤0.01%
735
-2,486
-77% -$179K
BTU icon
1663
Peabody Energy
BTU
$3B
$51K ﹤0.01%
+1,408
New +$56K
EVTC icon
1664
Evertec
EVTC
$1.78B
$51K ﹤0.01%
3,105
-2,378
-43% -$37.4K
HNI icon
1665
HNI Corp
HNI
$3.54B
$51K ﹤0.01%
1,414
+1,397
+8,218% +$53.4K
ROCK icon
1666
Gibraltar Industries
ROCK
$1.45B
$51K ﹤0.01%
1,500
+274
+22% +$9.51K
TRIB
1667
Trinity Biotech
TRIB
$9.11M
$51K ﹤0.01%
66
+5
+8% +$4.09K
MAXR
1668
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
$51K ﹤0.01%
1,100
+1,048
+2,015% +$58K
SITO
1669
DELISTED
SITO MOBILE, LTD
SITO
$51K ﹤0.01%
12,678
+3,390
+36% +$18.4K
QCP
1670
DELISTED
Quality Care Properties, Inc.
QCP
$51K ﹤0.01%
2,635
-2,224
-46% -$33.2K
AMPH icon
1671
Amphastar Pharmaceuticals
AMPH
$891M
$50K ﹤0.01%
+2,658
New +$50K
AMSF icon
1672
AMERISAFE
AMSF
$520M
$50K ﹤0.01%
+899
New +$52.5K
CCJ icon
1673
Cameco
CCJ
$42.5B
$50K ﹤0.01%
5,536
-2,322
-30% -$21.5K
LMAT icon
1674
LeMaitre Vascular
LMAT
$1.86B
$50K ﹤0.01%
+1,379
New +$47.8K
LNT icon
1675
Alliant Energy
LNT
$17.7B
$50K ﹤0.01%
1,222
+925
+311% +$36.5K

Similar funds

Tower Research Capital (TRC)'s Q1 2018 Portfolio in Review

As of Q1 2018, Tower Research Capital (TRC) held 4,355 positions worth $1.17B, up 51% from $775M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Tower Research Capital (TRC) deployed $459M of net new capital in Q1 2018, opening 842 new positions and adding to 1,505 existing holdings. Its largest new stake was iShares MSCI EAFE ETF: 717,758 shares worth $50M.

By sector, the portfolio is most concentrated in Financials at 6.7% of assets, down from 11% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $21M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2018 buy was iShares MSCI EAFE ETF: 717,758 shares worth $50M.
  • Tower Research Capital (TRC) added most to iShares MSCI Emerging Markets ETF in Q1 2018, an estimated $69.7M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $21M.
  • Tower Research Capital (TRC) fully exited Berkshire Hathaway Class B in Q1 2018, selling an estimated $7.94M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 24% of its $1.17B portfolio in Q1 2018.
  • Tower Research Capital (TRC) opened 842 new positions and closed 1,089 in Q1 2018.
  • Tower Research Capital (TRC)'s portfolio value rose 51% quarter-over-quarter to $1.17B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2018, filed 15 May 2018.